Individuals with type 2 diabetes mellitus (T2DM) often experience imbalances in their gut microbiota, along with psychiatric comorbidities like depression and anxiety.
Clinical Trial
A clinical trial investigated the effects of a high-fiber diet on the gut microbiota, serum metabolism, and emotional well-being of T2DM patients. Participants with T2DM were assigned to either consume a high-fiber diet or follow their regular diet as a control group. Glucose homeostasis, serum metabolome, systemic inflammation, and psychiatric comorbidities were assessed before and after the dietary intervention.Results
The high-fiber diet improved glucose homeostasis among the participants with T2DM. Additionally, dietary intervention positively influenced the serum metabolome, systemic inflammation, and psychiatric comorbidities. The abundance of beneficial gut microbes, including Lactobacillus, Bifidobacterium, and Akkermansias, increased in response to the high-fiber diet. On the other hand, the abundance of opportunistic pathogens like Desulfovibrio and Klebsielladecreased.Significance
The high-fiber diet positively impacted the gut microbiota composition, resulting in improved serum metabolism and emotional well-being for T2DM patients. The high-fiber diet created a healthier gut environment by increasing the presence of beneficial gut microbes and reducing the abundance of harmful pathogens.The changes in gut microbiota composition induced by the high-fiber diet played a crucial role in improving the overall health of T2DM patients. Not only did the dietary intervention positively influence glucose control, but it also had a broader impact on serum metabolome and emotional mood. By promoting a balanced and diverse gut microbiota, the high-fiber diet offered potential benefits for T2DM patients beyond glycemic control.
Conclusion
This study proves that a high-fiber diet can positively modulate the gut microbiota, improving serum metabolism and emotional well-being for individuals with T2DM. Incorporating more fiber-rich foods into the diet may be a valuable strategy for managing T2DM and its associated comorbidities, highlighting the importance of a healthy gut in overall health and well-being.__________
Frontiers in Cellular and Infection Microbiology, Jan-30-23
About Diabetes
Innovative Clinical Trials Study New Treatments for Diabetes
Diabetes Clinical Trial Gave Me a Fearless Life
Managing Depressing in Type 2 Diabetes with Melissa Officinalis Extract
Multicomponent Healthcare Intervention for Glycemic Control in Type 2 Diabetes
The Potential of Sleep-Opt-In for Type 1 Diabetes Management
Efficacy of Dorzagliatin as an Add-On Therapy in Diabetes
Benefits of Advanced Hybrid Closed Loop System for Type 1 Diabetes
Intermittent Fasting Shows Promise in Managing Type 2 Diabetes with Insulin Treatment
SGLT2 has been found to Protect Kidney Function in Diabetes
Clinical Trial Shows How to Reduce Risk of Kidney Stones in Diabetes
Clinical Trial Confirms the Link Between Obesity and Diabetes
Innovative Clinical Trials Study New Treatments for Diabetes
Medical Breakthrough for Type 1 Diabetes Patients
Could a Simple Blood Test Predict Diabetes?
About Diabetes
Innovative Clinical Trials Study New Treatments for Diabetes
Diabetes Clinical Trial Gave Me a Fearless Life
Managing Depressing in Type 2 Diabetes with Melissa Officinalis Extract
Multicomponent Healthcare Intervention for Glycemic Control in Type 2 Diabetes
The Potential of Sleep-Opt-In for Type 1 Diabetes Management
Efficacy of Dorzagliatin as an Add-On Therapy in Diabetes
Benefits of Advanced Hybrid Closed Loop System for Type 1 Diabetes
Intermittent Fasting Shows Promise in Managing Type 2 Diabetes with Insulin Treatment
SGLT2 has been found to Protect Kidney Function in Diabetes
Clinical Trial Shows How to Reduce Risk of Kidney Stones in Diabetes
Clinical Trial Confirms the Link Between Obesity and Diabetes
Innovative Clinical Trials Study New Treatments for Diabetes
Medical Breakthrough for Type 1 Diabetes Patients
Could a Simple Blood Test Predict Diabetes?